Factors influencing the recanalisation rate of deep venous thrombosis

International Angiology

Volumn 31, Issue 2, 2012, Pages 169-175

  Jezovnik, M K ^a   Poredos, P ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Biological markers; Fibrinolysis; Venous thrombosis

Indexed keywords

DALTEPARIN; INTERLEUKIN 6; PADGEM PROTEIN; WARFARIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE MARKER; DOPPLER ECHOGRAPHY; FEMALE; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PREDICTION; RECANALIZATION; RISK FACTOR;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULANTS; BIOLOGICAL MARKERS; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTTHROMBOTIC SYNDROME; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS;

EID: 84862182716     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Markel A. Origin and natural history of deep vein thrombosis of the legs. Semin Vasc Med 2005;5:65-74. (Pubitemid 40721047)
2. Markel A, Meissner M, Manzo RA, Bergelin RO, Strandness DE Jr. Deep venous thrombosis: rate of spontaneous lysis and thrombus extension. Int Angiol 2003;22:376-82. (Pubitemid 38324806)
3. Burnand KG, Gaffney PJ, McGuinness CL, Humphries J, Quarmby JW, Smith A. The role of the monocyte in the generation and dissolution of arterial and venous thrombi. Cardiovasc Surg 1998;6:119-25. (Pubitemid 28202240)
4. Meissner MH, Zierler BK, Bergelin RO, Chandler WL, Strandness DE Jr. Coagulation, fibrinolysis, and recanalization after acute deep venous thrombosis. J Vasc Surg 2002;35:278-85.
5. Northeast AD, Soo KS, Bobrow LG, Gaffney PJ, Burnand KG. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 1995;22:573-9.
6. van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002;116:173-7. (Pubitemid 34122078)
7. Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2004;2:619-22. (Pubitemid 40185686)
8. Pelzer H, Schwarz A, Stuber W Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991;65:153-9.
9. Killewich LA, Martin R, Cramer M, Beach KW, Strandness DE Jr. An objective assessment of the physiologic changes in the postthrombotic syndrome. Arch Surg 1985;120:424-6. (Pubitemid 15104018)
10. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984;76:393-7. (Pubitemid 14159549)
11. Killewich LA, Macko RF, Cox K, Franklin DR, Benjamin ME, Lilly MP et al. Regression of proximal deep venous thrombosis is associated with fibrinolytic enhancement. J Vasc Surg 1997;26:861-8. (Pubitemid 27505625)
12. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008;28:387-91.
13. Sevitt S. The mechanisms of canalisation in deep vein thrombosis. J Pathol 1973;110:153-65.
14. Arcelus JI, Caprini JA, Hoffman KN, Fink N, Size GP, Fareed J et al. Laboratory assays and Duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary results. J Vasc Surg 1996;23:616-21. (Pubitemid 26131819)
15. Jezovnik MK, Poredos P. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 2010;29:226-31.
16. Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003;1:1343-8.
17. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258-68.
18. Varma MR, Varga AJ, Knipp BS, Sukheepod P, Upchurch GR, Kunkel SL et al. Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 2003;38:1090-8. (Pubitemid 37409647)
19. Humphries J, McGuinness CL, Smith A, Waltham M, Poston R, Burnand KG. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 1999;30:894-9.
20. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proceedings of the National Academy of Sciences of the United States of America 2000;97:13835-40.
21. Proctor MC, Sullivan V, Zajkowski P, Wolk SW, Pomerantz RA, Wakefield TW et al. A role for interleukin-10 in the assessment of venous thromboembolism risk in injured patients. J Trauma 2006;60:147-51.
22. Dosquet C, Weill D, Wautier JL. Cytokines and thrombosis. J Cardiovasc Pharmacol 1995;25(Suppl 2):S13-9. (Pubitemid 26086251)